Reuters logo
BRIEF-Aerie Pharmaceuticals raises $125 mln
May 26, 2017 / 10:45 AM / 4 months ago

BRIEF-Aerie Pharmaceuticals raises $125 mln

May 26 (Reuters) - Aerie Pharmaceuticals Inc:

* Aerie Pharmaceuticals raises $125 million in ATM sales and upsized follow-on offering

* Aerie Pharmaceuticals -priced registered underwritten public offering of $75 million of shares of its common stock at a price to public of $53.75 per share

* Aerie Pharmaceuticals-to use proceeds to fund expansion of commercialization programs in north america for rhopressa, roclatan, among others

* Aerie Pharmaceuticals- $125 million is in addition to $50 million of shares sold through completion with Cantor Fitzgerald & Co Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below